GlassScriptPhysician profile
Nevinson P Sam
NPI 1497169213
$26,529.15
in general payments reported to CMS, 2019-2025
48 companies · $3,526 in 2025
The $3,526 reported for 2025 was more than what 90% of Pain Medicine (Anesthesiology) providers received nationally (typical 2025 total: $458).
See the full distribution for Pain Medicine (Anesthesiology)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $6,480 · 2020: $977 · 2021: $1,834 · 2022: $3,277 · 2023: $6,862 · 2024: $3,573 · 2025: $3,526.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $8,788 · Travel and Lodging: $5,173.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $8,787.97 |
| Travel and Lodging | $5,172.64 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $5,544.25 | 2019-2025 | Wavewriter Alpha Prime 16, Intracept, General - Pain Management |
| Mml US, INC. | $3,355.03 | 2023-2025 | Reactiv8 |
| Medtronic, INC. | $3,192.51 | 2021-2025 | Intellis Adaptivestim, Inceptiv, Synchromedii |
| Medtronic USA, INC. | $2,910.33 | 2019-2020 | |
| Relievant Medsystems, INC. | $1,440.43 | 2022-2023 | Intracept |
| Abbott Laboratories | $1,311.02 | 2019-2024 | Eterna, Proclaim |
| Vertiflex, INC. | $1,304.70 | 2019 | |
| Nevro Corp. | $1,278.93 | 2019-2024 | Senza |
| Flowonix Medical Incorporated | $796.33 | 2019 | |
| Saluda Medical Americas, INC. | $734.46 | 2023-2025 | Evoke, Evoke Scs |
| Collegium Pharmaceutical, INC. | $594.78 | 2019-2024 | Belbuca |
| Tersera Therapeutics LLC | $572.67 | 2019-2025 | Prialt |
| Abbvie INC. | $364.27 | 2021-2024 | Botox, Ubrelvy, Qulipta |
| Forte Bio-Pharma LLC | $332.88 | 2022-2025 | Prolate, Nalocet, Tanlor |
| Globus Medical, INC. | $299.07 | 2025 | Senza |
Show all 48 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Nevinson Sam listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.